These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 9933821)
1. Screening for Down's syndrome and neural tube defect in Croatia. A regional prospective study. Brajenović-Milić B; Tislarić D; Bacić J; Paravić J; Slivar AE; Kapovic M; Kosec V; Ristic S; Rajhvajn B Fetal Diagn Ther; 1998; 13(6):367-71. PubMed ID: 9933821 [TBL] [Abstract][Full Text] [Related]
2. [Second trimester maternal serum screening for Down's syndrome in mainland China: a multi-center prospective study]. Bian XM; Liu JT; Qi QW; Jiang YL; Li Y; Liu SY; Hao N; Zhou J; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Liao C; Cai Y; Wang H; Wang Z; Zhu J; Hu YL Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):805-9. PubMed ID: 19087560 [TBL] [Abstract][Full Text] [Related]
3. [Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study]. Qi QW; Jiang YL; Liu JT; Bian XM; Li Y; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Cai Y Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):737-41. PubMed ID: 19087538 [TBL] [Abstract][Full Text] [Related]
4. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization. McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age. Hsu JJ; Hsieh TT; Soong YK; Spencer K Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893 [TBL] [Abstract][Full Text] [Related]
6. Second trimester maternal serum screening using alpha fetoprotein, free beta human chorionic gonadotropin and maternal age specific risk: result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population. Chao AS; Chung CL; Wu CD; Chang SD; Cheng PJ; Lin YT; Soong YK Acta Obstet Gynecol Scand; 1999 May; 78(5):393-7. PubMed ID: 10326883 [TBL] [Abstract][Full Text] [Related]
7. Maternal serum screening in Ontario using the triple marker test. Summers AM; Farrell SA; Huang T; Meier C; Wyatt PR J Med Screen; 2003; 10(3):107-11. PubMed ID: 14561260 [TBL] [Abstract][Full Text] [Related]
8. Prenatal screening for Down's syndrome with use of maternal serum markers. Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344 [TBL] [Abstract][Full Text] [Related]
9. [Screening by maternal serum markers for Down's syndrome]. Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710 [TBL] [Abstract][Full Text] [Related]
10. Maternal serum screening for Down's syndrome, open neural tube defects and trisomy 18. Akbas SH; Ozben T; Alper O; Ugur A; Yücel G; Lüleci G Clin Chem Lab Med; 2001 Jun; 39(6):487-90. PubMed ID: 11506458 [TBL] [Abstract][Full Text] [Related]
11. Second trimester screening for Down's syndrome: 7 years experience. Beaman JM; Goldie DJ J Med Screen; 2001; 8(3):128-31. PubMed ID: 11678551 [TBL] [Abstract][Full Text] [Related]
12. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852 [TBL] [Abstract][Full Text] [Related]
13. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy. Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718 [TBL] [Abstract][Full Text] [Related]
14. Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review. Spencer K Br J Obstet Gynaecol; 1999 Dec; 106(12):1287-93. PubMed ID: 10609723 [TBL] [Abstract][Full Text] [Related]
15. The use of free beta-hCG in antenatal screening for Down's syndrome. Wald N; Densem J; Stone R; Cheng R Br J Obstet Gynaecol; 1993 Jun; 100(6):550-7. PubMed ID: 7687460 [TBL] [Abstract][Full Text] [Related]
16. A prospective clinical trial to compare the performance of dried blood spots prenatal screening for Down's syndrome with conventional non-invasive testing technology. Hu H; Jiang Y; Zhang M; Liu S; Hao N; Zhou J; Liu J; Zhang X; Ma L Exp Biol Med (Maywood); 2017 Mar; 242(5):547-553. PubMed ID: 28056555 [TBL] [Abstract][Full Text] [Related]
17. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening. Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311 [TBL] [Abstract][Full Text] [Related]